Steve Huggard Assesses Exposure of Pharmaceutical and Medical Device Executives to Criminal Liability in Bloomberg BNA's White Collar Crime Report

November 16, 2012 - Steve Huggard contributed an article examining the potential exposure of pharmaceutical and medical device executives to criminal liability in Bloomberg BNA's White Collar Crime Report. In the article, "Attention, Pharmaceutical and Medical Device Executives: Ignorance is Not Bliss," the authors analyze how the Apothecure, Synthes and Purdue prosecutions are examples of the FDA's recent commitment to increase the use of misdemeanor Park Doctrine prosecutions as a valuable enforcement tool.